Published in Ann Intern Med on October 01, 1982
Techniques for the recovery and identification of Cryptosporidium oocysts from stool specimens. J Clin Microbiol (1983) 6.16
Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol (1985) 5.22
Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev (1992) 5.11
Improved detection times for Mycobacterium avium complex and Mycobacterium tuberculosis with the BACTEC radiometric system. J Clin Microbiol (1985) 4.58
Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol (1983) 3.36
Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome. J Clin Microbiol (1987) 3.01
Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol (1986) 2.94
Laboratory diagnosis of mycobacterial infections in patients with acquired immunodeficiency syndrome. J Clin Microbiol (1986) 2.39
Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare. Antimicrob Agents Chemother (1985) 2.35
Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome. Clin Microbiol Rev (1989) 2.20
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest (1984) 2.10
Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy. J Clin Invest (1984) 2.07
The acquired immune deficiency syndrome. Clin Exp Immunol (1984) 1.62
Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrob Agents Chemother (1988) 1.46
Comparison of large restriction fragments of Mycobacterium avium isolates recovered from AIDS and non-AIDS patients with those of isolates from potable water. J Clin Microbiol (1999) 1.33
Susceptibility testing of Mycobacterium avium complex isolates. Antimicrob Agents Chemother (1996) 1.22
Isolation and geographic distribution of Mycobacterium other than M. tuberculosis in British Columbia, 1972-81. CMAJ (1985) 1.22
Acquired immune deficiency syndrome. Br Med J (Clin Res Ed) (1983) 1.19
Modified lymphocyte response to mitogens after intraperitoneal injection of glycopeptidolipid antigens from Mycobacterium avium complex. Infect Immun (1988) 1.13
In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrob Agents Chemother (1993) 1.13
Macrophage uptake and retention of radiolabeled glycopeptidolipid antigens associated with the superficial L1 layer of Mycobacterium intracellulare serovar 20. Infect Immun (1986) 1.12
Intra- and extracellular susceptibility of Mycobacterium avium-intracellulare complex to aminoglycoside antibiotics. Antimicrob Agents Chemother (1984) 1.08
Evaluation of abdominal pain in the AIDS patient. Ann Surg (1984) 1.05
Diagnosis of pulmonary complications of the acquired immune deficiency syndrome. Thorax (1985) 1.03
Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome. Evidence for an abnormality affecting individual helper and suppressor T cells. J Clin Invest (1985) 0.99
Isolation of Mycobacterium avium-intracellulare-scrofulaceum complex from faeces of patients with AIDS. Br Med J (Clin Res Ed) (1986) 0.97
Preservation of monocyte effector functions against Mycobacterium avium-M. intracellulare in patients with AIDS. Infect Immun (1991) 0.96
The acquired immune deficiency syndrome (AIDS)--a multidisciplinary enigma. West J Med (1984) 0.96
Wound infection rates after invasive procedures in HIV-1 seropositive versus HIV-1 seronegative hemophiliacs. Ann Surg (1990) 0.93
Reproducibility of lysis-centrifugation cultures for quantification of Mycobacterium avium complex bacteremia. J Clin Microbiol (1993) 0.89
Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection. Antimicrob Agents Chemother (1996) 0.88
Susceptibility of intra- and extracellular Mycobacterium avium-intracellulare to cephem antibiotics. Antimicrob Agents Chemother (1985) 0.86
Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individuals. J Clin Microbiol (1991) 0.86
Differences in antimicrobial susceptibility of pigmented and unpigmented colonial variants of Mycobacterium avium. J Clin Microbiol (1989) 0.85
Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications. Thorax (1990) 0.85
Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120. J Clin Invest (1994) 0.84
The diagnostic utility of bone marrow aspiration and biopsy in patients with acquired immunodeficiency syndrome. J Natl Med Assoc (1989) 0.83
Identification of a beta 1 integrin on Mycobacterium avium-Mycobacterium intracellulare. Infect Immun (1992) 0.83
Comparison of methods for isolating Mycobacterium avium-intracellulare from blood of patients with AIDS. J Clin Pathol (1988) 0.83
Granulomatous involvement of the liver in patients with AIDS. Gut (1985) 0.83
Cell-free system responsible for internal radiolabeling of glycopeptidolipids of the Mycobacterium avium complex. Infect Immun (1992) 0.82
Pulmonary complications of AIDS: a clinical strategy. CMAJ (1989) 0.82
General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection. J Pathog (2015) 0.79
Immunologic studies in asymptomatic hemophilia patients. Relationship to acquired immune deficiency syndrome (AIDS). J Clin Invest (1983) 0.79
Gastrointestinal manifestations of the acquired immunodeficiency syndrome. West J Med (1987) 0.79
Deficiency of immunity to Mycobacterium avium that can be restored by allogeneic lymphocytes. Clin Exp Immunol (1987) 0.78
Recovery of Mycobacterium avium-M. intracellulare from blood specimens by using the routine BACTEC 6B blood culture system. J Clin Microbiol (1989) 0.78
Mycobacterial disease associated with HIV infection. J Gen Intern Med (1991) 0.76
Mycobacterium avium-intracellulare and acute abdominal pain. West J Med (1994) 0.75
Mycobacterial infections in AIDS. Can J Infect Dis (1991) 0.75
Opportunistic infections and impaired cell-mediated immune responses in patients with the acquired immune deficiency syndrome. Trans Am Clin Climatol Assoc (1984) 0.75
Opportunistic infections in HIV-infected patients. Can J Infect Dis (1992) 0.75
Culture of Mycobacterium kansasii in the blood of an HIV negative patient. Thorax (1993) 0.75
Treatment of pulmonary disease caused by opportunist mycobacteria. Thorax (1989) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med (1999) 14.30
The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol (1993) 11.70
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med (1983) 10.09
An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med (1981) 7.35
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med (1999) 7.07
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med (1996) 7.06
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med (1984) 6.45
Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol (1993) 5.99
Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med (1986) 5.83
Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis (1983) 5.66
Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet (1986) 5.65
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25
Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature (1988) 5.21
A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet (1999) 4.96
Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis (1981) 4.77
Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother (1976) 4.55
Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. Am J Trop Med Hyg (1995) 4.32
Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol (1981) 4.24
Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med (1984) 3.73
Ecology of Ixodes dammini-borne human babesiosis and Lyme disease. Annu Rev Entomol (1985) 3.66
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55
Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med (1997) 3.53
Mice as reservoirs of the Lyme disease spirochete. Am J Trop Med Hyg (1985) 3.47
HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med (1997) 3.40
Tuberculous abscesses in patients with AIDS. Clin Infect Dis (1992) 3.40
Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis (1982) 3.38
A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. N Engl J Med (1992) 3.34
Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species. Am Rev Respir Dis (1984) 3.25
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science (1984) 3.20
Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16
The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med (1975) 3.06
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med (2001) 3.05
The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med (1978) 2.93
Use of lysis-centrifugation (isolator) and radiometric (BACTEC) blood culture systems for the detection of mycobacteremia. J Clin Microbiol (1985) 2.86
Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med (1993) 2.78
Kaposi's sarcoma in homosexual men-a report of eight cases. Lancet (1981) 2.75
NIH conference. The acquired immunodeficiency syndrome: an update. Ann Intern Med (1985) 2.68
Opportunistic pathogens in the genus Mycobacterium. Annu Rev Microbiol (1985) 2.67
Nosocomial infection caused by gentamicin-resistant, streptomycin-sensitive Klebsiella. J Infect Dis (1975) 2.66
NIH conference. Gastrointestinal infections in AIDS. Ann Intern Med (1992) 2.62
Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) (1975) 2.61
Inactivation of penicillins by carbohydrate solutions at alkaline pH. N Engl J Med (1970) 2.52
Serious infections caused by Streptococcus milleri. Am J Med (1978) 2.47
Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet (1985) 2.45
Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens. Antimicrob Agents Chemother (1979) 2.43
Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. Ann Intern Med (1988) 2.42
Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. J Immunol (1982) 2.42
Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41
Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome. J Clin Microbiol (1990) 2.35
Risk factors for transmission of Mycobacterium tuberculosis in a primary school outbreak: lack of racial difference in susceptibility to infection. Am J Epidemiol (1994) 2.34
The difficult road to truth and reconciliation--the health sector takes its first steps. Health and Human Rights Project Support Group. S Afr Med J (1998) 2.33
Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med (1988) 2.33
Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Intern Med (1993) 2.32
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest (1983) 2.32
Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1991) 2.31
Herpesvirus infections in the acquired immune deficiency syndrome. JAMA (1984) 2.25
Mycobacterial taxonomy. Eur J Clin Microbiol Infect Dis (1994) 2.23
Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis (1982) 2.20
Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med (1985) 2.18
Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am Rev Respir Dis (1973) 2.18
Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of human ehrlichiosis, in dogs from southeast Virginia. Am J Vet Res (1996) 2.17
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood (2000) 2.15
Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology (1984) 2.12
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). Am J Med (1993) 2.11
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest (1984) 2.10
Changing practices in mycobacteriology: a follow-up survey of state and territorial public health laboratories. J Clin Microbiol (1996) 2.06
Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates. J Infect Dis (1989) 2.04
Physician staffing in intensive-care units. Lancet (1996) 2.02
Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1996) 2.02
Serologic diagnosis of acute lymphadenopathic toxoplasmosis. J Infect Dis (1980) 1.99
The effect of azidothymidine on HIV-related thrombocytopenia. N Engl J Med (1988) 1.98
Analysis of mycolic acid cleavage products and cellular fatty acids of Mycobacterium species by capillary gas chromatography. J Clin Microbiol (1986) 1.97
Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med (1981) 1.96
Administrative guidelines for response to an adverse anesthesia event. The Risk Management Committee of the Harvard Medical School's Department of Anaesthesia. J Clin Anesth (1993) 1.94
The impact of disease severity on the informed consent process in clinical research. Am J Med (1996) 1.94
Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg (1986) 1.93
Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. J Infect Dis (1985) 1.92
Detection of Pneumocystis carinii by fluorescent-antibody stain using a combination of three monoclonal antibodies. J Clin Microbiol (1987) 1.90
Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med (1986) 1.89
The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage. Am Rev Respir Dis (1984) 1.88
Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med (1989) 1.88
Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers. Ann Intern Med (1984) 1.88
Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts. J Exp Med (1969) 1.86
Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.86
Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol (1994) 1.84
Drug interactions in patients infected with human immunodeficiency virus. Clin Infect Dis (1996) 1.82
Identification of antigens and antibodies specific for Pneumocystis carinii. J Immunol (1988) 1.81